@bedger Your comment about cash flow positive is at the nub of the matter. $587,000 revenue last quarter - much higher than next highest quarter - $482,000. If multiplied by four to get a full year's revenue - not bad at more than $2.3m. Market cap to sales ratio of about five to one - better then most medical companies. The problem is the very large losses - mostly to do with making the sales. If each quarter sales could increase without increasing costs - perhaps some hope.
@bedger Your comment about cash flow positive is at the nub of...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.006(9.38%) |
Mkt cap ! $7.319M | |||
| Open | High | Low | Value | Volume |
| 6.5¢ | 7.1¢ | 6.5¢ | $61.11K | 886.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14084 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 41666 | 1 |
View Market Depth
| Last trade - 10.15am 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.006 ( 8.66 %) |
||||
| Open | High | Low | Volume | ||
| 6.5¢ | 7.4¢ | 6.5¢ | 967097 | ||
| Last updated 10.30am 17/06/2024 ? | |||||
| OSX (ASX) Chart |